Amylyx Names New Chief Commercial Officer Ahead of GLP-1 …
1 day ago · Amylyx Pharmaceuticals named Dan Monahan as its chief commercial officer. 1 According to a press release, he is assuming the role in time to oversee the commercialization …
Amylyx Pharmaceuticals Appoints Dan Monahan as Chief …
5 days ago · - Dan Monahan will lead the commercialization strategy across Amylyx’ product portfolio, beginning with avexitide, an investigational, first-in-class glucagon-like peptide-1 …
Amylyx Pharmaceuticals Appoints Dan Monahan as Chief
5 days ago · Monahan will also join the Company’s Leadership Team. Mr. Monahan joined Amylyx in January 2024, bringing more than 20 years of commercial leadership experience in …
Amylyx appoints Dan Monahan as Chief Commercial Officer
5 days ago · Amylyx (AMLX) Pharmaceuticals announced the appointment of Dan Monahan as Chief Commercial Officer. Mr. Monahan will also join the Company’s Leadership Team. Mr. …
Amylyx Pharmaceuticals Appoints Dan Monahan as Chief …
4 days ago · Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the appointment of Dan Monahan as Chief Commercial Officer. Mr. Monahan will …
Amylyx names exec to lead GLP-1 receptor antagonist launch
4 days ago · Amylyx Pharmaceuticals has named Dan Monahan as chief commercial officer, positioning an exec who led the U.S. commercialization of Rexulti to oversee the planned …
Amylyx Pharmaceuticals Appoints Dan Monahan as Chief …
4 days ago · Dan served as a Field Artillery Officer in the U.S. Army. “I look forward to continuing to collaborate with the team on advancing novel therapies from development through …
Amylyx Pharmaceuticals Appoints Dan Monahan as Chief …
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the appointment of Dan Monahan as Chief Commercial Officer. Mr. Monahan will also join the …
Chutes & Ladders—Amylyx preps for GLP-1 launch with new CCO
11 hours ago · Dan Monahan, the exec who led Otsuka’s commercialization of Rexulti and Abilify Maintena, is taking command of the launch of Amylyx’s GLP-1 receptor antagonist avexitide …
Vendavo Announces New Chief Financial Officer | Vendavo
Denver, November 20, 2024— Vendavo, the global leader in B2B pricing, selling, and rebate solutions, today announced Dan Monahan’s appointment as Chief Financial Officer. Monahan …
- Some results have been removed